FDA recommending continue trial to support “traditional approval on gfr” is basically telling dimx to forget accelerated approval on protien-uria , not gonna happen. So in this ANN why they keep banging on about running a 2nd interim analysis for a “potential” accelerated conditional approval when fda has told them it’s not going to happen is just tone deaf imo.
my nephrology mate has been right all along about this
- Forums
- ASX - By Stock
- DXB
- Ann: Quarterly Appendix 4C and Activities Report
Ann: Quarterly Appendix 4C and Activities Report, page-17
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.0¢ |
Change
0.035(6.67%) |
Mkt cap ! $308.1M |
Open | High | Low | Value | Volume |
51.5¢ | 57.3¢ | 50.5¢ | $2.179M | 3.991M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 30558 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30558 | 0.560 |
3 | 25521 | 0.555 |
7 | 539331 | 0.550 |
3 | 15269 | 0.545 |
2 | 7430 | 0.540 |
Price($) | Vol. | No. |
---|---|---|
0.565 | 10000 | 1 |
0.570 | 73781 | 4 |
0.575 | 47975 | 3 |
0.580 | 122045 | 5 |
0.585 | 107509 | 5 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |